EAACI guidelines on allergen immunotherapy: Prevention of allergy
暂无分享,去创建一个
A. Sheikh | G. Toit | R. Van Ree | D. Larenas-Linnemann | N. Papadopoulos | D. Ryan | I. Agache | R. V. Wijk | A. Muraro | M. Calderón | G. Roberts | S. Halken | E. Angier | M. Fernández-Rivas | M. Jutel | S. Lau | G. Pajno | O. Pfaar | G. Sturm | E. Varga | U. Wahn | P. Matricardi | R. Ree | I. Ansotegui | S. Dhami | S. Arasi | F. Timmermans | J. Kleine‐Tebbe | Alexandra F. Santos | Alexandra F Santos | M. Penagos | M. Kristiansen | G. du Toit | Roy Geerth van Wijk | G. Roberts | R. van Ree | A. Sheikh
[1] A. Sheikh,et al. Challenges in the implementation of the EAACI AIT guidelines: A situational analysis of current provision of allergen immunotherapy , 2018, Allergy.
[2] A. Sheikh,et al. EAACI Guidelines on Allergen Immunotherapy: Allergic rhinoconjunctivitis , 2018, Allergy.
[3] P. Devillier,et al. Sublingual immunotherapy provides long‐term relief in allergic rhinitis and reduces the risk of asthma: A retrospective, real‐world database analysis , 2017, Allergy.
[4] E. Valovirta,et al. Results from the 5‐year SQ grass sublingual immunotherapy tablet asthma prevention (GAP) trial in children with grass pollen allergy , 2017, The Journal of allergy and clinical immunology.
[5] Joaquim Mullol,et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines—2016 revision , 2017, The Journal of allergy and clinical immunology.
[6] A. Sheikh,et al. Allergen immunotherapy for allergic asthma: A systematic review and meta‐analysis , 2017, Allergy.
[7] A. Sheikh,et al. Allergen immunotherapy for allergic rhinoconjunctivitis: A systematic review and meta‐analysis , 2017, Allergy.
[8] P. Demoly,et al. European Survey on Adverse Systemic Reactions in Allergen Immunotherapy (EASSI): a real‐life clinical assessment , 2017, Allergy.
[9] A. Sheikh,et al. Allergen immunotherapy for insect venom allergy: a systematic review and meta‐analysis , 2017, Allergy.
[10] A. Sheikh,et al. Allergen immunotherapy for the prevention of allergy: A systematic review and meta‐analysis , 2017, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.
[11] P. Demoly,et al. The European Survey on Adverse Systemic Reactions in Allergen Immunotherapy (EASSI): A paediatric assessment , 2017, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.
[12] S. Halken,et al. The prevalence of atopic diseases and the patterns of sensitization in adolescence , 2016, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.
[13] A. Bozek,et al. The effect of allergen-specific immunotherapy on offspring. , 2016, Allergy and asthma proceedings.
[14] A. Sheikh,et al. Allergen immunotherapy for the prevention of allergic disease: protocol for a systematic review , 2016, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.
[15] D. Larenas-Linnemann. Direct comparison of efficacy of sublingual immunotherapy tablets for rhinoconjunctivitis. , 2016, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[16] R. Van Ree,et al. International Consensus on Allergen Immunotherapy II: Mechanisms, standardization, and pharmacoeconomics. , 2016, The Journal of allergy and clinical immunology.
[17] D. Larenas-Linnemann,et al. Dosing of European sublingual immunotherapy maintenance solutions relative to monthly recommended dosing of subcutaneous immunotherapy. , 2016, Allergy and Asthma Proceedings.
[18] G. Roberts,et al. Randomized controlled trial of primary prevention of atopy using house dust mite allergen oral immunotherapy in early childhood. , 2015, The Journal of allergy and clinical immunology.
[19] J. Schmitt,et al. Allergy immunotherapy for allergic rhinitis effectively prevents asthma: Results from a large retrospective cohort study. , 2015, The Journal of allergy and clinical immunology.
[20] C. Bachert,et al. Allergen immunotherapy on the way to product-based evaluation—a WAO statement , 2015, The World Allergy Organization journal.
[21] G. Roberts,et al. Changing prevalence of wheeze, rhinitis and allergic sensitisation in late childhood: findings from 2 Isle of Wight birth cohorts 12 years apart , 2015, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[22] R. Van Ree,et al. International consensus on allergy immunotherapy. , 2015, The Journal of allergy and clinical immunology.
[23] S. Thomsen,et al. Incidence rates of atopic dermatitis, asthma, and allergic rhinoconjunctivitis in Danish and Swedish children. , 2015, The Journal of allergy and clinical immunology.
[24] A. Plaia,et al. Efficacy of Grass Pollen Allergen Sublingual Immunotherapy Tablets for Seasonal Allergic Rhinoconjunctivitis: A Systematic Review and Meta-analysis. , 2015, JAMA internal medicine.
[25] K. Takeuchi,et al. Immunological parameters in prophylactic sublingual immunotherapy in asymptomatic subjects sensitized to Japanese cedar pollen. , 2015, Allergology international : official journal of the Japanese Society of Allergology.
[26] H. Sitter,et al. Guideline on allergen-specific immunotherapy in IgE-mediated allergic diseases , 2014, Allergo Journal International.
[27] R. Valenta,et al. Preventive sublingual immunotherapy in preschool children: First evidence for safety and pro‐tolerogenic effects , 2014, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.
[28] S. Simoens,et al. Economic burden of inadequate management of allergic diseases in the European Union: a GA2LEN review , 2014, Allergy.
[29] E. Valovirta,et al. Allergy and asthma prevention 2014 , 2014, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.
[30] A. Sheikh,et al. EAACI Food Allergy and Anaphylaxis Guidelines. Food allergy health-related quality of life measures. , 2014, Allergy.
[31] A. Sheikh,et al. EAACI Food Allergy and Anaphylaxis Guidelines. Primary prevention of food allergy , 2014, Allergy.
[32] Xiaoping Lin,et al. [Efficacy evaluation of standardized dust mite allergen specific immunotherapy to patients of allergic rhinitis]. , 2014, Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology, head, and neck surgery.
[33] A. Sheikh,et al. The epidemiology of food allergy in Europe: a systematic review and meta‐analysis , 2014, Allergy.
[34] P. Sly,et al. Prophylactic use of sublingual allergen immunotherapy in high-risk children: a pilot study. , 2013, The Journal of allergy and clinical immunology.
[35] S. Halken,et al. The natural course of sensitization and allergic diseases from childhood to adulthood , 2013, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.
[36] J. Bousquet,et al. Grading local side effects of sublingual immunotherapy for respiratory allergy: speaking the same language. , 2013, The Journal of allergy and clinical immunology.
[37] C. Li,et al. Long-term Efficacy of Specific Immunotherapy on House Dust Mite–Induced Allergic Rhinitis in China , 2013, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
[38] EAACI Food Allergy and Anaphylaxis Guidelines , 2013 .
[39] R. Dominicus. 3-years' long-term effect of subcutaneous immunotherapy (SCIT) with a high-dose hypoallergenic 6-grass pollen preparation in adults. , 2012, European annals of allergy and clinical immunology.
[40] E. Valovirta,et al. Design and recruitment for the GAP trial, investigating the preventive effect on asthma development of an SQ-standardized grass allergy immunotherapy tablet in children with grass pollen-induced allergic rhinoconjunctivitis. , 2011, Clinical therapeutics.
[41] G. Giles,et al. Childhood eczema and rhinitis predict atopic but not nonatopic adult asthma: a prospective cohort study over 4 decades. , 2011, The Journal of allergy and clinical immunology.
[42] Michelle E. Kho,et al. AGREE II: advancing guideline development, reporting and evaluation in health care , 2010, Canadian Medical Association Journal.
[43] Gene Feder,et al. AGREE II: advancing guideline development, reporting and evaluation in health care. , 2010, Journal of clinical epidemiology.
[44] T. Keil,et al. Allergic rhinitis as a predictor for wheezing onset in school-aged children. , 2010, The Journal of allergy and clinical immunology.
[45] G. Canonica,et al. Long-lasting effects of sublingual immunotherapy according to its duration: a 15-year prospective study. , 2010, The Journal of allergy and clinical immunology.
[46] R. Lockey,et al. Speaking the same language: The World Allergy Organization Subcutaneous Immunotherapy Systemic Reaction Grading System. , 2010, The Journal of allergy and clinical immunology.
[47] K. Harmancı,et al. Evaluation of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. , 2010, Asian Pacific journal of allergy and immunology.
[48] M. Fernández-Rivas,et al. Sublingual immunotherapy in peach allergy: monitoring molecular sensitizations and reactivity to apple fruit and Platanus pollen. , 2010, Journal of investigational allergology & clinical immunology.
[49] T. Brüning,et al. Allergen content of grass pollen preparations for skin prick testing and sublingual immunotherapy , 2009, Allergy.
[50] Y. Nakai,et al. Immunotherapy for cure and prophylaxis of allergic rhinitis , 2009 .
[51] L. Lynd,et al. Economic burden of asthma: a systematic review , 2009, BMC pulmonary medicine.
[52] G. Canonica,et al. Preventive effects of sublingual immunotherapy in childhood: an open randomized controlled study. , 2008, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[53] P. Lieberman,et al. Epidemiology of Anaphylaxis , 2009 .
[54] J. Maloney. Long-term Immunologic Effects of Broad-Spectrum Aeroallergen Immunotherapy , 2007, Pediatrics.
[55] D. Johns,et al. Childhood allergic rhinitis predicts asthma incidence and persistence to middle age: a longitudinal study. , 2007, The Journal of allergy and clinical immunology.
[56] E. Valovirta,et al. Specific immunotherapy has long‐term preventive effect of seasonal and perennial asthma: 10‐year follow‐up on the PAT study , 2007, Allergy.
[57] D. Can,et al. Development of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. , 2007, Asian Pacific journal of allergy and immunology.
[58] C. M. Reha,et al. Specific immunotherapy is effective in the prevention of new sensitivities. , 2007, Allergologia et immunopathologia.
[59] A. Graham,et al. Evidence-Based Medicine: Levels of Evidence and Grades of Recommendation , 2007 .
[60] Y. Sertdemir,et al. Prevention of new sensitizations by specific immunotherapy in children with rhinitis and/or asthma monosensitized to house dust mite. , 2007, Journal of investigational allergology & clinical immunology.
[61] S Dreborg,et al. Five‐year follow‐up on the PAT study: specific immunotherapy and long‐term prevention of asthma in children , 2006, Allergy.
[62] K. C. Brown,et al. Long-Term Immunologic Effects of Broad-Spectrum Aeroallergen Immunotherapy , 2006, International Archives of Allergy and Immunology.
[63] P. Eng,et al. Twelve‐year follow‐up after discontinuation of preseasonal grass pollen immunotherapy in childhood , 2006, Allergy.
[64] G. Passalacqua,et al. Randomized controlled open study of sublingual immunotherapy for respiratory allergy in real‐life: clinical efficacy and more , 2004, Allergy.
[65] S. Burastero,et al. Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis. , 2004, The Journal of allergy and clinical immunology.
[66] C. Vancheri,et al. A randomized, controlled study of specific immunotherapy in monosensitized subjects with seasonal rhinitis: effect on bronchial hyperresponsiveness, sputum inflammatory markers and development of asthma symptoms. , 2004, Annali italiani di medicina interna : organo ufficiale della Societa italiana di medicina interna.
[67] R. Asero. Injection Immunotherapy with Different Airborne Allergens Did Not Prevent de novo Sensitization to Ragweed and Birch Pollen North of Milan , 2004, International Archives of Allergy and Immunology.
[68] G. Passalacqua,et al. Long‐lasting effect of sublingual immunotherapy in children with asthma due to house dust mite: a 10‐year prospective study , 2003, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[69] G. Feder,et al. Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: the AGREE project , 2003, Quality & safety in health care.
[70] F. Cluzeau,et al. Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: the AGREE project , 2003 .
[71] J. Bartra,et al. Effects of specific immunotherapy on the development of new sensitisations in monosensitised patients. , 2003, Allergologia et immunopathologia.
[72] A. Boner,et al. Benefits of immunotherapy with a standardized Dermatophagoides pteronyssinus extract in asthmatic children: a three‐year prospective study , 2002, Allergy.
[73] P. Eng,et al. Long‐term efficacy of preseasonal grass pollen immunotherapy in children , 2002, Allergy.
[74] S. Guerra,et al. Rhinitis as an independent risk factor for adult-onset asthma. , 2002, The Journal of allergy and clinical immunology.
[75] Erkka Valovirta,et al. Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study). , 2002, The Journal of allergy and clinical immunology.
[76] N. York,et al. Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A six‐year follow‐up study. , 2001, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[77] R. Merendino,et al. Prevention of new sensitizations in monosensitized subjects submitted to specific immunotherapy or not. A retrospective study , 2001, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[78] R. Djukanović,et al. Effects of specific immunotherapy in allergic rhinitic individuals with bronchial hyperresponsiveness. , 2000, American journal of respiratory and critical care medicine.
[79] J Bousquet,et al. Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper. , 1998, The Journal of allergy and clinical immunology.
[80] H. Løwenstein,et al. Immunotherapy with partially purified and standardized tree pollen extracts. IV. Results from long‐term (6‐year) follow‐up , 1997, Allergy.
[81] J. Bousquet,et al. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. VI. Specific immunotherapy prevents the onset of new sensitizations in children. , 1997, The Journal of allergy and clinical immunology.
[82] H. Ipsen,et al. Immunotherapy with partially purified and standardized tree pollen extracts , 1988, Allergy.
[83] B. Björkstén,et al. Oral Immunotherapy of Children with Rhinoconjunctivitis due to Birch Pollen Allergy A Double Blind Study , 1986, Allergy.